104 related articles for article (PubMed ID: 9117256)
1. Ex vivo expansion of hematopoietic progenitors from CD34+ cells selected from leukapheresis products of lymphoma and myeloma patients: feasibility and enhancement by fibronectin.
Mahé B; Pineau D; Robillard N; Accard F; Hermouet S
J Hematother; 1996 Dec; 5(6):671-9. PubMed ID: 9117256
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
3. In vitro expansion of CD34+ cells from peripheral blood of myeloma and lymphoma patients.
Mahe B; Menard A; Accard F; Pineau D; Robillard N; Hermouet S
Nouv Rev Fr Hematol (1978); 1995; 37(6):335-41. PubMed ID: 8907629
[TBL] [Abstract][Full Text] [Related]
4. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
Villaron EM; Almeida J; Lopez-Holgado N; Sanchez-Guijo FM; Alberca M; Blanco B; Sanchez-Abarca LI; Lopez O; Perez-Simon JA; San Miguel JF; del Cañizo MC
Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836
[TBL] [Abstract][Full Text] [Related]
5. Circulating stem cell collection in lymphoma and myeloma after mobilization with cyclophosphamide and granulocyte colony-stimulating factor for autologous transplantation.
Cancelas JA; Hernández-Jodra M; Zamora C; Perez-Oteyza J; Brieva JA; Roldan E; Navas G; Garcia-Laraña J; Lopez J; Odriozola J
Vox Sang; 1994; 67(4):362-7. PubMed ID: 7535498
[TBL] [Abstract][Full Text] [Related]
6. Standardization of the CFU-GM assay: Advantages of plating a fixed number of CD34+ cells in collagen gels.
Dobo I; Pineau D; Robillard N; Geneviève F; Piard N; Zandecki M; Hermouet S
J Hematother Stem Cell Res; 2003 Oct; 12(5):543-51. PubMed ID: 14594511
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.
Siena S; Bregni M; Brando B; Belli N; Ravagnani F; Gandola L; Stern AC; Lansdorp PM; Bonadonna G; Gianni AM
Blood; 1991 Jan; 77(2):400-9. PubMed ID: 1702334
[TBL] [Abstract][Full Text] [Related]
8. Fate of contaminating t(14; 18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells.
Widmer L; Pichert G; Jost LM; Stahel RA
Blood; 1996 Oct; 88(8):3166-75. PubMed ID: 8874217
[TBL] [Abstract][Full Text] [Related]
9. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
10. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of L-selectin, VLA-4, and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery.
Möhle R; Murea S; Kirsch M; Haas R
Exp Hematol; 1995 Dec; 23(14):1535-42. PubMed ID: 8542944
[TBL] [Abstract][Full Text] [Related]
12. Expansion of blood CD34+ cells: committed precursor expansion does not affect immature hematopoietic progenitors.
David S; Boiron JM; Dupouy M; Rice A; Vianes I; Duperray V; Reiffers J
J Hematother; 1997 Apr; 6(2):151-8. PubMed ID: 9131445
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
Ruggieri L; Heimfeld S; Broxmeyer HE
Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
[TBL] [Abstract][Full Text] [Related]
14. Animal serum-free culture of purified human CD34+ cells: amplification of progenitors from G-CSF and GM-CSF-mobilized peripheral blood.
Schain LR; Jain S; Wysocki M; Hall M; Dadey B; Pennathur-Das R; Biddle W; Wolf J; Okarma TB; Lebkowski JS
J Hematother; 1997 Aug; 6(4):335-49. PubMed ID: 9377072
[TBL] [Abstract][Full Text] [Related]
15. High-dose therapy with peripheral blood progenitor cell support in patients with non-Hodgkin's lymphoma.
Haas R; Murea S; Goldschmidt H; Döhner H; Moos M; Witt B; Eugenhart R; Wannenmacher M; Hunstein W
Stem Cells; 1995 Dec; 13 Suppl 3():28-35. PubMed ID: 8747986
[TBL] [Abstract][Full Text] [Related]
16. Persistence of residual tumour cells after cytokine-mediated ex vivo expansion of mobilized CD34+ blood cells in multiple myeloma.
Van Riet I; Juge-Morineau N; Schots R; De Waele M; De Greef C; Thielemans K; Van Camp B; Bakkus M
Br J Haematol; 1997 Feb; 96(2):403-11. PubMed ID: 9029033
[TBL] [Abstract][Full Text] [Related]
17. Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses.
Dobo I; Robillard N; Pineau D; Geneviève F; Piard N; Rapp MJ; Boasson M; Zandecki M; Hermouet S
Ann Hematol; 2001 Nov; 80(11):639-46. PubMed ID: 11757722
[TBL] [Abstract][Full Text] [Related]
18. The effect of short G-CSF administration on the numbers and clonogenic efficiency of hematopoietic progenitor cells in bone marrow and peripheral blood of normal donors.
Zaucha JM; Knopińska-Posłuszny W; Bieniaszewska M; Myśliwski A; Hellmann A
Ann Transplant; 2000; 5(4):20-6. PubMed ID: 11499355
[TBL] [Abstract][Full Text] [Related]
19. The potential role of FLT3 ligand in progenitor and primitive hematopoietic cell expansion.
Poloni A; Douay L; Giarratana MC; Kobari L; Gorin NC; Olivieri A; Leoni P
Boll Soc Ital Biol Sper; 1997; 73(3-4):55-62. PubMed ID: 9540233
[TBL] [Abstract][Full Text] [Related]
20. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
